Jonny Kinzi graduated in Medicinal and Industrial Pharmaceutical Sciences from the Institute of Pharmaceutical Sciences at ETH Zurich in 2017. During the master he successfully wrote his thesis in Proteomics and HLA-Peptidomics at Philochem AG (Otelfingen). In 2017 he joined Novartis as an intern and continued to work there as a formulation scientist. Jonny joined in August 2019 the Biopharmacy Research group and started his PhD investigating the pharmacological and physiological role of OATP2B1 in a novel rat model.